Form D · Other
Novel Microdevices, Inc.
Baltimore, MD · CIK 0001837242
Offering snapshot reported Apr 27, 2026 · SEC filing
- Reported sold
- $1M Offering amount: $8M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 27, 2026 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Jan 7, 2025 | Initial | $567,000 | No comparison | 1 | SEC filing |
| Jan 5, 2024 | Initial | $1,850,000 | No comparison | 3 | SEC filing |
| Jan 17, 2023 | Amendment | $4,375,000 | $2,000,000vs Apr 28, 2022 | 29 | SEC filing |
| Apr 28, 2022 | Amendment | $2,375,000 | $675,000vs Feb 2, 2022 | 22 | SEC filing |
| Feb 2, 2022 | Amendment | $1,700,000 | $975,000vs Dec 21, 2020 | 16 | SEC filing |
| Nov 1, 2021 | Amendment | $1,375,000 | $0vs Oct 29, 2021 | 10 | SEC filing |
| Oct 29, 2021 | Amendment | $1,375,000 | $875,000vs Feb 25, 2021 | 10 | SEC filing |
| Feb 25, 2021 | Amendment | $1,275,000 | $550,000vs Dec 21, 2020 | 9 | SEC filing |
| Feb 25, 2021 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Dec 21, 2020 | Initial | $725,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-581949
Convertible Promissory Note
Source: Form D, filed Apr 27, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Deborah Hemingway | Director |
| Michael Niggel | Director |
| Andrea Pais | Director, Executive |
| Robert Storey | Director |
| Steve Yannaras | Director |
Issuer details
Industry: Other (See others in industry)
Address:
101 West Dickman Street Suite 300
Baltimore, MD, 21230
Baltimore, MD, 21230